LT3324948T - Daugiasluoksnės farmaciniu požiūriu aktyvaus junginio atpalaidavimo mikrodalelės skystoje vaisto formoje - Google Patents
Daugiasluoksnės farmaciniu požiūriu aktyvaus junginio atpalaidavimo mikrodalelės skystoje vaisto formojeInfo
- Publication number
- LT3324948T LT3324948T LTEPPCT/EP2016/066597T LT16066597T LT3324948T LT 3324948 T LT3324948 T LT 3324948T LT 16066597 T LT16066597 T LT 16066597T LT 3324948 T LT3324948 T LT 3324948T
- Authority
- LT
- Lithuania
- Prior art keywords
- multilayered
- dosage form
- active compound
- pharmaceutically active
- liquid dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15177221.7A EP3117824A1 (en) | 2015-07-17 | 2015-07-17 | Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form |
| BE20165555A BE1024339B1 (fr) | 2016-07-01 | 2016-07-01 | Microparticules multicouches libérant un composé pharmaceutiquement actif dans une forme pharmaceutique liquide |
| PCT/EP2016/066597 WO2017012935A1 (en) | 2015-07-17 | 2016-07-13 | Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3324948T true LT3324948T (lt) | 2023-03-27 |
Family
ID=56409108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/EP2016/066597T LT3324948T (lt) | 2015-07-17 | 2016-07-13 | Daugiasluoksnės farmaciniu požiūriu aktyvaus junginio atpalaidavimo mikrodalelės skystoje vaisto formoje |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20190008787A1 (lt) |
| EP (1) | EP3324948B1 (lt) |
| JP (1) | JP6796132B2 (lt) |
| KR (1) | KR102633566B1 (lt) |
| CN (1) | CN108348475B (lt) |
| AU (1) | AU2016294734B2 (lt) |
| CA (1) | CA2992356C (lt) |
| DK (1) | DK3324948T3 (lt) |
| ES (1) | ES2944568T3 (lt) |
| FI (1) | FI3324948T3 (lt) |
| HR (1) | HRP20230250T1 (lt) |
| HU (1) | HUE061861T2 (lt) |
| LT (1) | LT3324948T (lt) |
| PL (1) | PL3324948T3 (lt) |
| RS (1) | RS64088B1 (lt) |
| SI (1) | SI3324948T1 (lt) |
| WO (1) | WO2017012935A1 (lt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107638333A (zh) * | 2017-09-29 | 2018-01-30 | 点铂医疗科技（常州）有限公司 | 一种茶多酚/壳聚糖微粒及其制备方法 |
| GB201716716D0 (en) | 2017-10-12 | 2017-11-29 | Univ Of Hertfordshire Higher Education Corporation | Method for coating particles |
| BR112020013398A2 (pt) * | 2018-01-03 | 2020-12-01 | Ferring B.V. | composições farmacêuticas líquidas orais de aminossalicilatos |
| CN111789808A (zh) * | 2019-04-08 | 2020-10-20 | 生达化学制药股份有限公司 | 口服医药组成物及其结构 |
| EP4072532B1 (en) * | 2019-12-11 | 2024-01-24 | Evonik Operations GmbH | Dosage form for use in treating or preventing of a disease |
| US20220071913A1 (en) * | 2020-09-10 | 2022-03-10 | Sawai Pharmaceutical Co., Ltd. | Granule, preparation containing the granule, production method of the granule, and production method of preparation containing the granule |
| KR20230071712A (ko) * | 2021-11-16 | 2023-05-23 | 오즈온바이오 주식회사 | 산 민감성 무기성분을 포함하는 삼투성 제제 조성물 |
| CN115300506A (zh) * | 2022-08-11 | 2022-11-08 | 南京红地生物科技有限公司 | 含有坦索罗辛和米拉贝隆的复方制剂及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| DK0419861T3 (da) * | 1989-08-29 | 1996-03-04 | Boehringer Ingelheim Pharma | Anvendelse af dibenz(b,f) (1,4)oxazepin (og thiazepin)-11(10H)-oner og -thioner til fremstilling af farmaceutisk præparat til forebyggelse eller behandling af AIDS |
| FR2774288B1 (fr) | 1998-01-30 | 2001-09-07 | Ethypharm Sa | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques |
| DK1146862T3 (da) | 1999-01-29 | 2003-07-21 | Disphar Int Bv | Farmaceutiske sammensætninger |
| US20040006109A1 (en) | 2002-07-03 | 2004-01-08 | Rajneesh Taneja | Liquid dosage forms of non-enterically coated acid-labile drugs |
| US20040005362A1 (en) | 2002-07-03 | 2004-01-08 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
| CN1938026A (zh) | 2004-03-26 | 2007-03-28 | 卫材R&D管理有限公司 | 控释制剂及其制造方法 |
| US20060134210A1 (en) | 2004-12-22 | 2006-06-22 | Astrazeneca Ab | Solid dosage form comprising proton pump inhibitor and suspension made thereof |
| US20070098746A1 (en) * | 2005-11-02 | 2007-05-03 | Nichols William M | Multi-layered coating technology for taste masking |
| WO2011107855A2 (en) * | 2010-03-04 | 2011-09-09 | Torrent Pharmaceuticals Limited | Sustained release oral liquid suspension dosage form |
| DE102010052847A1 (de) * | 2010-11-29 | 2012-05-31 | Temmler Werke Gmbh | Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung |
| DK4011364T3 (da) * | 2011-03-23 | 2024-03-18 | Ironshore Pharmaceuticals & Dev Inc | Fremgangsmåder og sammensætninger til behandling af ADD (Attention Deficit Disorder) |
-
2016
- 2016-07-13 HR HRP20230250TT patent/HRP20230250T1/hr unknown
- 2016-07-13 DK DK16738185.4T patent/DK3324948T3/da active
- 2016-07-13 PL PL16738185.4T patent/PL3324948T3/pl unknown
- 2016-07-13 WO PCT/EP2016/066597 patent/WO2017012935A1/en unknown
- 2016-07-13 LT LTEPPCT/EP2016/066597T patent/LT3324948T/lt unknown
- 2016-07-13 FI FIEP16738185.4T patent/FI3324948T3/fi active
- 2016-07-13 KR KR1020187004004A patent/KR102633566B1/ko active IP Right Grant
- 2016-07-13 JP JP2018521698A patent/JP6796132B2/ja active Active
- 2016-07-13 RS RS20230244A patent/RS64088B1/sr unknown
- 2016-07-13 CN CN201680054102.9A patent/CN108348475B/zh active Active
- 2016-07-13 AU AU2016294734A patent/AU2016294734B2/en active Active
- 2016-07-13 CA CA2992356A patent/CA2992356C/en active Active
- 2016-07-13 US US15/745,190 patent/US20190008787A1/en active Pending
- 2016-07-13 ES ES16738185T patent/ES2944568T3/es active Active
- 2016-07-13 SI SI201631681T patent/SI3324948T1/sl unknown
- 2016-07-13 HU HUE16738185A patent/HUE061861T2/hu unknown
- 2016-07-13 EP EP16738185.4A patent/EP3324948B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20230250T1 (hr) | 2023-04-14 |
| HUE061861T2 (hu) | 2023-08-28 |
| JP2018521137A (ja) | 2018-08-02 |
| EP3324948B1 (en) | 2023-02-15 |
| CA2992356A1 (en) | 2017-01-26 |
| WO2017012935A1 (en) | 2017-01-26 |
| AU2016294734A1 (en) | 2018-02-01 |
| US20190008787A1 (en) | 2019-01-10 |
| DK3324948T3 (da) | 2023-05-08 |
| RS64088B1 (sr) | 2023-04-28 |
| SI3324948T1 (sl) | 2023-05-31 |
| ES2944568T3 (es) | 2023-06-22 |
| CN108348475B (zh) | 2022-01-04 |
| CA2992356C (en) | 2024-02-13 |
| PL3324948T3 (pl) | 2023-06-26 |
| JP6796132B2 (ja) | 2020-12-02 |
| KR102633566B1 (ko) | 2024-02-05 |
| CN108348475A (zh) | 2018-07-31 |
| EP3324948A1 (en) | 2018-05-30 |
| AU2016294734B2 (en) | 2021-01-28 |
| FI3324948T3 (fi) | 2023-05-05 |
| KR20180042853A (ko) | 2018-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE061861T2 (hu) | Többrétegû, gyógyászatilag aktív vegyületet leadó mikroszemcsék folyékony dózisformában | |
| IL259530A (en) | Different devices and methods for drug release | |
| IL252144A0 (en) | Training in period division | |
| IL240849B (en) | Drug delivery devices and drug delivery method | |
| GB201406928D0 (en) | Liquid dosage form and delivery system | |
| ZA201607581B (en) | Dosage forms and therapeutic uses l-4lchlorokynurenine | |
| PT3324948T (pt) | Micropartícula multicamada numa forma de dosagem líquida para libertação de composto farmaceuticamente ativo | |
| GB201501475D0 (en) | A medicament delivery device | |
| HUE050640T2 (hu) | Gyógyszeradagoló | |
| HK1223833A1 (zh) | 藥物劑型 | |
| HK1223630A1 (zh) | 抗- 療法的實施與用量 | |
| ZA201800586B (en) | A drug delivery device | |
| EP2968179A4 (en) | RETARD-PRESENTATIONS | |
| PT2910223T (pt) | Emplastro com dispensador de medicação | |
| HK1257934A1 (zh) | 製造藥物遞送裝置的方法和根據該方法製成的藥物遞送裝置 | |
| GB201404358D0 (en) | Improvements in drug delivery inhalar devices | |
| HRP20181406T1 (hr) | Farmaceutski dozni oblici |